Digene Fights Antitrust Charges As Part Of HPV Diagnostics Patent Case

Human papillomavirus test maker Digene, recently acquired by Qiagen, is defending itself against allegations of anti-competitive business practices from Third Wave Technologies as part of a larger patent battle between the firms